Rong Jiang

1.7k total citations · 1 hit paper
38 papers, 1.2k citations indexed

About

Rong Jiang is a scholar working on Reproductive Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Rong Jiang has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 11 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Rong Jiang's work include Ovarian cancer diagnosis and treatment (11 papers), Intraperitoneal and Appendiceal Malignancies (8 papers) and Cancer-related molecular mechanisms research (4 papers). Rong Jiang is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Intraperitoneal and Appendiceal Malignancies (8 papers) and Cancer-related molecular mechanisms research (4 papers). Rong Jiang collaborates with scholars based in China, United States and Canada. Rong Jiang's co-authors include Radha Duttagupta, Jeremy Gollub, Keith Jones, Robert Getts, Liwei Sun, Bin Wang, Jinduo Li, Rongyu Zang, Tingyan Shi and Sheng Yin and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Rong Jiang

36 papers receiving 1.2k citations

Hit Papers

Secondary cytoreduction followed by chemotherapy versus c... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rong Jiang China 15 489 383 273 221 185 38 1.2k
Kyoo Wan Choi South Korea 20 373 0.8× 162 0.4× 320 1.2× 416 1.9× 345 1.9× 56 1.6k
Xian Chen China 19 387 0.8× 110 0.3× 188 0.7× 41 0.2× 82 0.4× 64 1.1k
J.-L. Brun France 21 108 0.2× 94 0.2× 529 1.9× 417 1.9× 116 0.6× 83 1.3k
Tobias Weissenbacher Germany 16 165 0.3× 160 0.4× 40 0.1× 67 0.3× 241 1.3× 40 717
Koji Izumi Japan 22 399 0.8× 188 0.5× 69 0.3× 808 3.7× 371 2.0× 102 1.7k
Tian Li China 20 223 0.5× 100 0.3× 48 0.2× 78 0.4× 159 0.9× 83 1.1k
Gary T. Burger United States 17 211 0.4× 417 1.1× 58 0.2× 244 1.1× 353 1.9× 31 1.3k
Guodong Liu China 18 470 1.0× 334 0.9× 19 0.1× 150 0.7× 253 1.4× 59 1.1k
Israel Henig Israel 17 272 0.6× 28 0.1× 242 0.9× 53 0.2× 180 1.0× 62 1.0k

Countries citing papers authored by Rong Jiang

Since Specialization
Citations

This map shows the geographic impact of Rong Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Jiang more than expected).

Fields of papers citing papers by Rong Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Jiang. The network helps show where Rong Jiang may publish in the future.

Co-authorship network of co-authors of Rong Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Jiang. A scholar is included among the top collaborators of Rong Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Jiang. Rong Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Rong, Yanling Feng, Xi Cheng, et al.. (2024). Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nature Medicine. 30(8). 2181–2188. 14 indexed citations
4.
Shi, Tingyan, Jianqing Zhu, Yanling Feng, et al.. (2021). Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology. 22(4). 439–449. 131 indexed citations breakdown →
5.
Wang, Jun, et al.. (2020). Diagnostic Value of Sestrin2 in Patients with Obstructive Sleep Apnea. Metabolic Syndrome and Related Disorders. 18(8). 362–367. 4 indexed citations
6.
Liu, Zhigang, Chenyang Xu, Rong Jiang, et al.. (2019). Treatment of Locally Advanced Nasopharyngeal Carcinoma by Helical Tomotherapy: An Observational, Prospective Analysis. Translational Oncology. 12(5). 757–763. 7 indexed citations
7.
Hou, Chao, Dong Wang, Xiang Li, et al.. (2019). MANF regulates splenic macrophage differentiation in mice. Immunology Letters. 212. 37–45. 22 indexed citations
8.
Shi, Tingyan, Rong Jiang, Jinjin Yu, et al.. (2018). Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial. British Journal of Cancer. 119(1). 12–18. 7 indexed citations
9.
Shi, Tingyan, Pan Wang, Rong Jiang, et al.. (2018). Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer. Cellular Physiology and Biochemistry. 47(5). 2088–2096. 10 indexed citations
10.
Tian, Dandan, Rong Jiang, Xuejun Chen, & Qing Ye. (2017). Meteorological factors on the incidence of MP and RSV pneumonia in children. PLoS ONE. 12(3). e0173409–e0173409. 40 indexed citations
12.
Sun, Liwei, et al.. (2016). Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages. Cellular Immunology. 311. 86–93. 133 indexed citations
13.
Jeyanathan, Mangalakumari, Zhongqi Shao, Xue‐Feng Yu, et al.. (2015). AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates. PLoS ONE. 10(8). e0135009–e0135009. 46 indexed citations
14.
Ren, Yu, Tingyan Shi, Rong Jiang, et al.. (2015). Multiple Cycles of Neoadjuvant Chemotherapy Associated With Poor Survival in Bulky Stage IIIC and IV Ovarian Cancer. International Journal of Gynecological Cancer. 25(8). 1398–1404. 13 indexed citations
15.
Liu, Ying, Rong Jiang, Rui Ding, et al.. (2014). Plasminogen Activator Inhibitor-1 -675 4G/5G Polymorphism and Polycystic Ovary Syndrome Risk: A Meta Analysis. Journal of Assisted Reproduction and Genetics. 31(3). 363–370. 10 indexed citations
16.
Xue, Xiang, Jie Tang, Xi Cheng, et al.. (2012). Evaluation of Risk Factors for Venous Thromboembolism in Chinese Women With Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 23(1). 65–72. 19 indexed citations
17.
McCarren, Madeline, Hong Qiu, Najat J. Ziyadeh, et al.. (2012). Follow-Up Study of a Pharmacovigilance Signal. Journal of Clinical Psychopharmacology. 32(6). 743–749. 4 indexed citations
18.
Duttagupta, Radha, Rong Jiang, Jeremy Gollub, Robert Getts, & Keith Jones. (2011). Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures. PLoS ONE. 6(6). e20769–e20769. 257 indexed citations
19.
Dennis, S., Jalid Sehouli, Claes G. Tropé, et al.. (2011). A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection. Annals of Surgical Oncology. 19(2). 597–604. 90 indexed citations
20.
Kim, Sung Hoon, Keyan Zhao, Rong Jiang, et al.. (2006). Association Mapping With Single-Feature Polymorphisms. Genetics. 173(2). 1125–1133. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026